Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-11

FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal Pharmaceuticals LLC's generic valsartan/hydrochlorothiazide tablet for hypertension under an original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan and Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

ORIG AP for VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)